Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -119.79x is 91% below its 5-year average of -62.82x, near the low end of its 5-year range (-119.79x–-5.85x).
As of the fiscal period ended Sunday, December 31, 2023.
Reported quarterly interest coverage; no daily interpolation. Q4 FY2023 (2023-12-31): -119.79x.
INTEREST COVERAGE RATIO
-119.79x
INTEREST COVERAGE RATIO AVG TTM
N/A
INTEREST COVERAGE RATIO AVG 3Y
N/A
INTEREST COVERAGE RATIO AVG 5Y
-62.82x
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
-90.69%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-5.54x
median of 448 covered companies
CURRENT VS SECTOR MEDIAN
-2062.19%
vs the sector median at left
Adial Pharmaceuticals, Inc.
Market Cap
$11.69M
Interest Coverage Ratio
-119.79x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
-62.82x
Market Cap
$11.62M
Interest Coverage Ratio
-1171.55x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$11.52M
Interest Coverage Ratio
-20.24x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$11.54M
Interest Coverage Ratio
26.76x
TTM Avg
26.76x
3Y Avg
26.76x
5Y Avg
26.76x
Market Cap
$11.44M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$11.30M
Interest Coverage Ratio
-473.91x
TTM Avg
210.31x
3Y Avg
210.31x
5Y Avg
210.31x
Market Cap
$12.54M
Interest Coverage Ratio
-16.47x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Adial Pharmaceuticals, Inc. (ADIL) | $11.69M | -119.79x | N/A | N/A | -62.82x |
| Bullfrog AI Holdings, Inc. Common Stock (BFRG)vs › | $11.62M | -1171.55x | N/A | N/A | N/A |
| Biofrontera Inc. (BFRI)vs › | $11.52M | -20.24x | N/A | N/A | N/A |
| Pluri Inc. (PLUR)vs › | $11.54M | 26.76x | 26.76x | 26.76x | 26.76x |
| Phio Pharmaceuticals Corp. (PHIO)vs › | $11.44M | N/A | N/A | N/A | N/A |
| Kiora Pharmaceuticals, Inc. (KPRX)vs › | $11.30M | -473.91x | 210.31x | 210.31x | 210.31x |
| BioVie Inc. (BIVI)vs › | $11.08M | -1265.39x | N/A | N/A | N/A |
| Cerenome, Inc. (CNSY)vs › | $11.36M | -4.24x | N/A | N/A | N/A |
| Dare Bioscience, Inc. (DARE)vs › | $12.54M | -16.47x | N/A | N/A | N/A |
| Cytosorbents Corporation (CTSO)vs › | $12.60M | -5.45x | 0.92x | 0.92x | 0.92x |
Interest Coverage
-119.8x
Debt/Equity
0.00
Current Ratio
5.63
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2023-12-31 | -119.79x |
| 2018-12-31 | -5.85x |
| 2018-09-30 | -4.35x |
| 2018-06-30 | -34.22x |
| 2018-03-31 | -6.57x |
| 2017-12-31 | -3.91x |
| 2017-09-30 | -8.69x |
| 2017-06-30 | -10.58x |
| 2017-03-31 | -18.23x |
| 2016-12-31 | -10.96x |
| 2016-09-30 | -61.72x |
